Menopause Midterm Practice Questions
with 100% Correct Answers 2025
JW, a 53-year-old post-menopausal female, presents to the pharmacy with a new
prescription for 17β- estradiol topical gel (EstroGel) for vasomotor symptom relief.
Which of the following is the appropriate administration of 17β- estradiol topical gel
(EstroGel)?
A. Apply 1 pump depression once daily to one arm from wrist to shoulder
B. Apply 1 pump depression once daily to one upper arm and shoulder area
C. Apply 1 packet once daily to one upper thigh
D. Apply 1 pouch once daily to each thigh and calf
A.
JW, a 53-year-old post-menopausal female, presents to the pharmacy with a new
prescription for 17β- estradiol topical gel (EstroGel) for vasomotor symptom relief.
Which statement should be included in the counseling for 17β- estradiol topical gel
(EstroGel)?
A. Apply gel after applying lotion, powder, or oil
B. Washing hands after application is not necessary
C. Allow gel to dry before dressing
D. Massage or rub in gel after application
C.
CG is a 55-year-old post-menopausal woman seeking treatment for vasomotor
symptoms. She has an intact uterus and a history of breast cancer.
Which of the following patient data is an absolute contraindication to hormone
replacement therapy?
A. Former smoker
B. Current treatment for type 2 diabetes
C. History of breast cancer
D. Family history of CHD
C.
CG is a 55-year-old post-menopausal woman seeking treatment for vasomotor
symptoms. She has an intact uterus and a history of breast cancer.
Which treatment is most appropriate for this patient?
A. Micronized 17β- estradiol (Estrace)
B. Venlafaxine (Effexor)
C. Ospemifene (Osphena)
D. Raloxifene (Evista)
B.
HC, a 52-year-old female, has been prescribed a continuous combined oral estrogen
and progestogen product for vasomotor symptom relief related to menopause. She has
read about the potential risks associated with HRT and would like to discuss these
Menopause
, Menopause
before filling the prescription.
Which of the following strategies will help reduce the incidence of breast cancer?
A. Limit duration of use to 5 years
B. Use bioidentical HRT instead
C. Use transdermal estrogen instead
D. Use phytoestrogens instead
A.
HC, a 52-year-old female, has been prescribed a continuous combined oral estrogen
and progestogen product for vasomotor symptom relief related to menopause. She has
read about the potential risks associated with HRT and would like to discuss these
before filling the prescription.
Which of the following strategies will help reduce the incidence of VTE?
A. Use transdermal estrogen instead
B. Use black cohosh instead
C. Use a product with medroxyprogesterone acetate
B.
HC, a 52-year-old female, has been prescribed a continuous combined oral estrogen
and progestogen product for vasomotor symptom relief related to menopause. She has
read about the potential risks associated with HRT and would like to discuss these
before filling the prescription.
Which of the following are vaginal tablets and are not taken orally and are administered
vaginally? (Select ALL THAT APPLY)
A. Imvexxy
B. Duavee
C. Vagifem
D. Activella
A.
Chief complaint: Pain with sexual intercourse
History of present illness: OR is a 46-year-old female presenting to the office today for
an annual follow-up complaining of pain with sexual intercourse. She recently started
taking Estroven Maximum Strength® but has noted little benefit. She denies other
menopausal symptoms.
Past medical history: Gestational DM with first pregnancy
Surgical history: Hysterectomy (2016) secondary to fibroids, ovaries remain
Social history: (-) for tobacco, EtOH, and illicit drugs
Family history: (-) for breast and cervical cancer
Current nonprescription medications: Centrum multivitamin one tablet daily, ibuprofen
200 mg one tablet as needed
Current complementary and alternative medications: Estroven Maximum Strength® one
caplet daily
Menopause